ID   ERG7_HUMAN              Reviewed;         732 AA.
AC   P48449; B4DJZ9; D3DSN0; E9PEI9; G5E9Q9; Q8IYL6; Q9UEZ1;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Lanosterol synthase;
DE            EC=5.4.99.7;
DE   AltName: Full=2,3-epoxysqualene--lanosterol cyclase;
DE   AltName: Full=Oxidosqualene--lanosterol cyclase;
DE            Short=OSC;
DE            Short=hOSC;
GN   Name=LSS; Synonyms=OSC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RC   TISSUE=Liver;
RX   PubMed=7639730; DOI=10.1006/bbrc.1995.2110;
RA   Baker C.H., Matsuda S.P.T., Liu D.R., Corey E.J.;
RT   "Molecular cloning of the human gene encoding lanosterol synthase from
RT   a liver cDNA library.";
RL   Biochem. Biophys. Res. Commun. 213:154-160(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RX   PubMed=8593458; DOI=10.1248/bpb.18.1459;
RA   Sung C.K., Shibuya M., Sankawa U., Ebizuka Y.;
RT   "Molecular cloning of cDNA encoding human lanosterol synthase.";
RL   Biol. Pharm. Bull. 18:1459-1461(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   VAL-642.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10598817; DOI=10.1007/s004390051135;
RA   Roessler E., Mittaz L., Du Y., Scott H.S., Chang J., Rossier C.,
RA   Guipponi M., Matsuda S.P., Muenke M., Antonarakis S.E.;
RT   "Structure of the human lanosterol synthase gene and its analysis as a
RT   candidate for holoprosencephaly.";
RL   Hum. Genet. 105:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   VAL-642.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-642.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-5, CATALYTIC ACTIVITY, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14766201; DOI=10.1016/j.bbrc.2004.01.052;
RA   Ruf A., Muller F., D'Arcy B., Stihle M., Kusznir E., Handschin C.,
RA   Morand O.H., Thoma R.;
RT   "The monotopic membrane protein human oxidosqualene cyclase is active
RT   as monomer.";
RL   Biochem. Biophys. Res. Commun. 315:247-254(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 41-630 (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=8655142; DOI=10.1007/BF02281872;
RA   Young M., Chen H., Lalioti M.D., Antonarakis S.E.;
RT   "The human lanosterol synthase gene maps to chromosome 21q22.3.";
RL   Hum. Genet. 97:620-624(1996).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   FUNCTION, INVOLVEMENT IN CTRCT44, VARIANTS CTRCT44 ARG-581 AND
RP   SER-588, AND CHARACTERIZATION OF VARIANTS CTRCT44 ARG-581 AND SER-588.
RX   PubMed=26200341; DOI=10.1038/nature14650;
RA   Zhao L., Chen X.J., Zhu J., Xi Y.B., Yang X., Hu L.D., Ouyang H.,
RA   Patel S.H., Jin X., Lin D., Wu F., Flagg K., Cai H., Li G., Cao G.,
RA   Lin Y., Chen D., Wen C., Chung C., Wang Y., Qiu A., Yeh E., Wang W.,
RA   Hu X., Grob S., Abagyan R., Su Z., Tjondro H.C., Zhao X.J., Luo H.,
RA   Hou R., Perry J.J., Gao W., Kozak I., Granet D., Li Y., Sun X.,
RA   Wang J., Zhang L., Liu Y., Yan Y.B., Zhang K.;
RT   "Lanosterol reverses protein aggregation in cataracts.";
RL   Nature 523:607-611(2015).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEXES WITH LANOSTEROL AND
RP   RO 48-807, AND SUBCELLULAR LOCATION.
RX   PubMed=15525992; DOI=10.1038/nature02993;
RA   Thoma R., Schulz-Gasch T., D'Arcy B., Benz J., Aebi J., Dehmlow H.,
RA   Hennig M., Stihle M., Ruf A.;
RT   "Insight into steroid scaffold formation from the structure of human
RT   oxidosqualene cyclase.";
RL   Nature 432:118-122(2004).
CC   -!- FUNCTION: Catalyzes the cyclization of (S)-2,3 oxidosqualene to
CC       lanosterol, a reaction that forms the sterol nucleus. Through the
CC       production of lanosterol may regulate lens protein aggregation and
CC       increase transparency. {ECO:0000269|PubMed:26200341,
CC       ECO:0000269|PubMed:7639730}.
CC   -!- CATALYTIC ACTIVITY: (3S)-2,3-epoxy-2,3-dihydrosqualene =
CC       lanosterol. {ECO:0000269|PubMed:14766201,
CC       ECO:0000269|PubMed:7639730}.
CC   -!- PATHWAY: Terpene metabolism; lanosterol biosynthesis; lanosterol
CC       from farnesyl diphosphate: step 3/3.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:14766201}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:14766201, ECO:0000269|PubMed:15525992};
CC       Peripheral membrane protein {ECO:0000269|PubMed:14766201,
CC       ECO:0000269|PubMed:15525992}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P48449-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48449-2; Sequence=VSP_045407;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P48449-3; Sequence=VSP_046188;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Cataract 44 (CTRCT44) [MIM:616509]: An opacification of
CC       the crystalline lens of the eye that frequently results in visual
CC       impairment or blindness. Opacities vary in morphology, are often
CC       confined to a portion of the lens, and may be static or
CC       progressive. In general, the more posteriorly located and dense an
CC       opacity, the greater the impact on visual function.
CC       {ECO:0000269|PubMed:26200341}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the terpene cyclase/mutase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U22526; AAC50184.1; -; mRNA.
DR   EMBL; D63807; BAA09875.1; -; mRNA.
DR   EMBL; S81221; AAB36220.1; -; mRNA.
DR   EMBL; AJ239031; CAB42828.1; -; Genomic_DNA.
DR   EMBL; AJ239021; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239022; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239023; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239024; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239025; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239026; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239027; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239028; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239029; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239030; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AK296313; BAG59011.1; -; mRNA.
DR   EMBL; AK226141; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AP001468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09299.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09301.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09302.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09303.1; -; Genomic_DNA.
DR   EMBL; BC035638; AAH35638.1; -; mRNA.
DR   EMBL; X87809; CAA61078.1; -; mRNA.
DR   CCDS; CCDS13733.1; -. [P48449-1]
DR   CCDS; CCDS46654.1; -. [P48449-3]
DR   CCDS; CCDS54489.1; -. [P48449-2]
DR   PIR; JC4194; JC4194.
DR   RefSeq; NP_001001438.1; NM_001001438.2. [P48449-1]
DR   RefSeq; NP_001138908.1; NM_001145436.1. [P48449-3]
DR   RefSeq; NP_001138909.1; NM_001145437.1. [P48449-2]
DR   RefSeq; NP_002331.3; NM_002340.5. [P48449-1]
DR   RefSeq; XP_016883835.1; XM_017028346.1. [P48449-1]
DR   RefSeq; XP_016883836.1; XM_017028347.1. [P48449-3]
DR   UniGene; Hs.596543; -.
DR   PDB; 1W6J; X-ray; 2.20 A; A=1-732.
DR   PDB; 1W6K; X-ray; 2.10 A; A=1-732.
DR   PDBsum; 1W6J; -.
DR   PDBsum; 1W6K; -.
DR   ProteinModelPortal; P48449; -.
DR   SMR; P48449; -.
DR   BioGrid; 110225; 14.
DR   IntAct; P48449; 8.
DR   STRING; 9606.ENSP00000348762; -.
DR   BindingDB; P48449; -.
DR   ChEMBL; CHEMBL3593; -.
DR   DrugBank; DB03696; Lanosterol.
DR   DrugBank; DB02016; R048-8071.
DR   GuidetoPHARMACOLOGY; 2434; -.
DR   SwissLipids; SLP:000000646; -.
DR   SwissLipids; SLP:000001308; -. [P48449-1]
DR   iPTMnet; P48449; -.
DR   PhosphoSitePlus; P48449; -.
DR   SwissPalm; P48449; -.
DR   BioMuta; LSS; -.
DR   DMDM; 1352387; -.
DR   EPD; P48449; -.
DR   MaxQB; P48449; -.
DR   PaxDb; P48449; -.
DR   PeptideAtlas; P48449; -.
DR   PRIDE; P48449; -.
DR   DNASU; 4047; -.
DR   Ensembl; ENST00000356396; ENSP00000348762; ENSG00000160285. [P48449-1]
DR   Ensembl; ENST00000397728; ENSP00000380837; ENSG00000160285. [P48449-1]
DR   Ensembl; ENST00000457828; ENSP00000409191; ENSG00000160285. [P48449-2]
DR   Ensembl; ENST00000522411; ENSP00000429133; ENSG00000160285. [P48449-3]
DR   GeneID; 4047; -.
DR   KEGG; hsa:4047; -.
DR   UCSC; uc002zij.4; human. [P48449-1]
DR   CTD; 4047; -.
DR   DisGeNET; 4047; -.
DR   GeneCards; LSS; -.
DR   HGNC; HGNC:6708; LSS.
DR   HPA; CAB034116; -.
DR   HPA; HPA032060; -.
DR   HPA; HPA032062; -.
DR   MalaCards; LSS; -.
DR   MIM; 600909; gene.
DR   MIM; 616509; phenotype.
DR   neXtProt; NX_P48449; -.
DR   OpenTargets; ENSG00000160285; -.
DR   PharmGKB; PA30473; -.
DR   eggNOG; KOG0497; Eukaryota.
DR   eggNOG; COG1657; LUCA.
DR   GeneTree; ENSGT00390000011570; -.
DR   HOGENOM; HOG000234317; -.
DR   HOVERGEN; HBG005604; -.
DR   InParanoid; P48449; -.
DR   KO; K01852; -.
DR   OMA; REWIEGM; -.
DR   OrthoDB; EOG091G02LL; -.
DR   PhylomeDB; P48449; -.
DR   TreeFam; TF300406; -.
DR   BioCyc; MetaCyc:HS08480-MONOMER; -.
DR   BRENDA; 5.4.99.7; 2681.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   UniPathway; UPA00767; UER00753.
DR   ChiTaRS; LSS; human.
DR   EvolutionaryTrace; P48449; -.
DR   GeneWiki; Lanosterol_synthase; -.
DR   GenomeRNAi; 4047; -.
DR   PRO; PR:P48449; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000160285; -.
DR   CleanEx; HS_LSS; -.
DR   ExpressionAtlas; P48449; baseline and differential.
DR   Genevisible; P48449; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005811; C:lipid particle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0000250; F:lanosterol synthase activity; IMP:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:UniProtKB.
DR   GO; GO:0006694; P:steroid biosynthetic process; IMP:UniProtKB.
DR   CDD; cd02892; SQCY_1; 1.
DR   InterPro; IPR032696; SQ_cyclase_C.
DR   InterPro; IPR032697; SQ_cyclase_N.
DR   InterPro; IPR018333; Squalene_cyclase.
DR   InterPro; IPR002365; Terpene_synthase_CS.
DR   InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR   Pfam; PF13243; SQHop_cyclase_C; 1.
DR   Pfam; PF13249; SQHop_cyclase_N; 1.
DR   SUPFAM; SSF48239; SSF48239; 2.
DR   TIGRFAMs; TIGR01787; squalene_cyclas; 1.
DR   PROSITE; PS01074; TERPENE_SYNTHASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cataract;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Endoplasmic reticulum; Isomerase; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Polymorphism; Reference proteome; Repeat;
KW   Steroid biosynthesis.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:14766201}.
FT   CHAIN         2    732       Lanosterol synthase.
FT                                /FTId=PRO_0000072659.
FT   REPEAT      124    165       PFTB 1.
FT   REPEAT      483    528       PFTB 2.
FT   REPEAT      560    600       PFTB 3.
FT   REPEAT      612    653       PFTB 4.
FT   ACT_SITE    232    232       Proton acceptor.
FT   ACT_SITE    455    455       Proton donor. {ECO:0000305}.
FT   MOD_RES       2      2       N-acetylthreonine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ       1     80       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_045407.
FT   VAR_SEQ     133    143       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046188.
FT   VARIANT     175    175       R -> Q (in dbSNP:rs2839158).
FT                                /FTId=VAR_024648.
FT   VARIANT     310    310       H -> R (in dbSNP:rs34115287).
FT                                /FTId=VAR_052057.
FT   VARIANT     581    581       W -> R (in CTRCT44; loss of lanosterol
FT                                synthase activity; dbSNP:rs864622780).
FT                                {ECO:0000269|PubMed:26200341}.
FT                                /FTId=VAR_075664.
FT   VARIANT     588    588       G -> S (in CTRCT44; loss of lanosterol
FT                                synthase activity; dbSNP:rs561449819).
FT                                {ECO:0000269|PubMed:26200341}.
FT                                /FTId=VAR_075665.
FT   VARIANT     614    614       R -> W (in dbSNP:rs35785446).
FT                                /FTId=VAR_052058.
FT   VARIANT     642    642       L -> V (in dbSNP:rs2254524).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_021522.
FT   VARIANT     688    688       P -> L (in dbSNP:rs17293705).
FT                                /FTId=VAR_052059.
FT   CONFLICT    348    348       W -> R (in Ref. 4; CAB42828).
FT                                {ECO:0000305}.
FT   HELIX        22     24       {ECO:0000244|PDB:1W6K}.
FT   STRAND       25     30       {ECO:0000244|PDB:1W6K}.
FT   STRAND       33     38       {ECO:0000244|PDB:1W6K}.
FT   STRAND       40     45       {ECO:0000244|PDB:1W6J}.
FT   HELIX        50     56       {ECO:0000244|PDB:1W6K}.
FT   TURN         61     63       {ECO:0000244|PDB:1W6K}.
FT   HELIX        73     85       {ECO:0000244|PDB:1W6K}.
FT   STRAND      101    103       {ECO:0000244|PDB:1W6K}.
FT   HELIX       104    115       {ECO:0000244|PDB:1W6K}.
FT   HELIX       123    134       {ECO:0000244|PDB:1W6K}.
FT   HELIX       151    163       {ECO:0000244|PDB:1W6K}.
FT   HELIX       171    182       {ECO:0000244|PDB:1W6K}.
FT   HELIX       186    188       {ECO:0000244|PDB:1W6K}.
FT   HELIX       191    199       {ECO:0000244|PDB:1W6K}.
FT   HELIX       205    207       {ECO:0000244|PDB:1W6K}.
FT   HELIX       213    217       {ECO:0000244|PDB:1W6K}.
FT   HELIX       226    228       {ECO:0000244|PDB:1W6K}.
FT   HELIX       231    245       {ECO:0000244|PDB:1W6K}.
FT   HELIX       254    260       {ECO:0000244|PDB:1W6K}.
FT   HELIX       268    270       {ECO:0000244|PDB:1W6K}.
FT   HELIX       274    276       {ECO:0000244|PDB:1W6K}.
FT   HELIX       282    284       {ECO:0000244|PDB:1W6K}.
FT   HELIX       291    305       {ECO:0000244|PDB:1W6K}.
FT   HELIX       309    330       {ECO:0000244|PDB:1W6K}.
FT   HELIX       337    351       {ECO:0000244|PDB:1W6K}.
FT   HELIX       356    363       {ECO:0000244|PDB:1W6K}.
FT   HELIX       366    368       {ECO:0000244|PDB:1W6K}.
FT   STRAND      369    372       {ECO:0000244|PDB:1W6K}.
FT   STRAND      375    378       {ECO:0000244|PDB:1W6K}.
FT   STRAND      380    382       {ECO:0000244|PDB:1W6K}.
FT   HELIX       385    398       {ECO:0000244|PDB:1W6K}.
FT   HELIX       401    403       {ECO:0000244|PDB:1W6K}.
FT   HELIX       405    407       {ECO:0000244|PDB:1W6K}.
FT   HELIX       408    421       {ECO:0000244|PDB:1W6K}.
FT   HELIX       430    433       {ECO:0000244|PDB:1W6K}.
FT   STRAND      443    445       {ECO:0000244|PDB:1W6K}.
FT   TURN        447    449       {ECO:0000244|PDB:1W6K}.
FT   HELIX       454    470       {ECO:0000244|PDB:1W6K}.
FT   HELIX       480    491       {ECO:0000244|PDB:1W6K}.
FT   STRAND      502    504       {ECO:0000244|PDB:1W6K}.
FT   HELIX       510    515       {ECO:0000244|PDB:1W6K}.
FT   HELIX       531    547       {ECO:0000244|PDB:1W6K}.
FT   HELIX       553    570       {ECO:0000244|PDB:1W6K}.
FT   STRAND      580    584       {ECO:0000244|PDB:1W6K}.
FT   HELIX       585    598       {ECO:0000244|PDB:1W6K}.
FT   HELIX       610    620       {ECO:0000244|PDB:1W6K}.
FT   HELIX       634    638       {ECO:0000244|PDB:1W6K}.
FT   HELIX       649    661       {ECO:0000244|PDB:1W6K}.
FT   HELIX       667    680       {ECO:0000244|PDB:1W6K}.
FT   STRAND      694    696       {ECO:0000244|PDB:1W6K}.
FT   TURN        697    699       {ECO:0000244|PDB:1W6K}.
FT   STRAND      700    702       {ECO:0000244|PDB:1W6K}.
FT   HELIX       707    722       {ECO:0000244|PDB:1W6K}.
FT   HELIX       727    729       {ECO:0000244|PDB:1W6K}.
SQ   SEQUENCE   732 AA;  83309 MW;  E4708A5AE53585ED CRC64;
     MTEGTCLRRR GGPYKTEPAT DLGRWRLNCE RGRQTWTYLQ DERAGREQTG LEAYALGLDT
     KNYFKDLPKA HTAFEGALNG MTFYVGLQAE DGHWTGDYGG PLFLLPGLLI TCHVARIPLP
     AGYREEIVRY LRSVQLPDGG WGLHIEDKST VFGTALNYVS LRILGVGPDD PDLVRARNIL
     HKKGGAVAIP SWGKFWLAVL NVYSWEGLNT LFPEMWLFPD WAPAHPSTLW CHCRQVYLPM
     SYCYAVRLSA AEDPLVQSLR QELYVEDFAS IDWLAQRNNV APDELYTPHS WLLRVVYALL
     NLYEHHHSAH LRQRAVQKLY EHIVADDRFT KSISIGPISK TINMLVRWYV DGPASTAFQE
     HVSRIPDYLW MGLDGMKMQG TNGSQIWDTA FAIQALLEAG GHHRPEFSSC LQKAHEFLRL
     SQVPDNPPDY QKYYRQMRKG GFSFSTLDCG WIVSDCTAEA LKAVLLLQEK CPHVTEHIPR
     ERLCDAVAVL LNMRNPDGGF ATYETKRGGH LLELLNPSEV FGDIMIDYTY VECTSAVMQA
     LKYFHKRFPE HRAAEIRETL TQGLEFCRRQ QRADGSWEGS WGVCFTYGTW FGLEAFACMG
     QTYRDGTACA EVSRACDFLL SRQMADGGWG EDFESCEERR YLQSAQSQIH NTCWAMMGLM
     AVRHPDIEAQ ERGVRCLLEK QLPNGDWPQE NIAGVFNKSC AISYTSYRNI FPIWALGRFS
     QLYPERALAG HP
//
